Insmed sees full-year 2020 arikayce revenue of $180 million to $220 million

Insmed - sees full-year 2020 arikayce revenue of $180 million to $220 million.insmed - anticipates a potential launch of arikayce in germany by end of 2020, followed shortly thereafter by uk.insmed - expects adjusted operating expenses to be in the range of $340 million to $360 million for 2020.

INSM Ratings Summary

INSM Quant Ranking